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2Abstract1
2
Polycystic ovary syndrome (PCOS) is a heterogeneous disease characterized by 3
hyperandrogenemia, hirsutism, oligo- or amenorrhea, insulin resistance and 4
anovulation. The aim of the present study was to evaluate if the balance between the 5
ovarian expression of Bax (proapoptotic protein) and Bcl-2 (antiapoptotic protein) is 6
altered in a PCOS model developed in rats by DHEA administration. In addition, the 7
ovarian morphology and the circulating progesterone levels were evaluated. 8
Histological studies confirmed the presence of follicular cysts, atretic follicles and the 9
absence of corpora lutea in the ovaries from the PCOS group and a significant decrease 10
in circulating progesterone levels. Immunohistochemical studies showed that the 11
expression of Bcl-2 and Bax were mainly localized in granulosa cells of antral follicles 12
in both groups. Bax expression was greater in preantral and antral follicles from PCOS 13
ovarian sections than in Controls. In contrast, intense Bcl-2 immunostaining was 14
observed in Control antral follicles, while Bcl-2 protein was either absent in preantral 15
follicles or weakly expressed in antral follicles from PCOS rats. These results were 16
partially confirmed by western studies. Data revealed that the ovarian level of Bcl-2 17
protein was lower in PCOS than in Control, and that there were no differences in Bax 18
ovarian levels between groups. However, Bax/ Bcl-2 ratio was significantly higher in 19
PCOS group than in Control group. In conclusion, an increase in ovarian apoptosis 20
through an imbalance among the Bcl-2 family members may be involved in the 21
transformation of growing follicles in cystic follicles in the ovaries from DHEA-22
induced PCOS rats. 23
24
25
26
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3Introduction 1
2
Infertility affects 10% of human couples, a proportion of which are due to ovarian 3
dysfunction. Polycystic ovary syndrome (PCOS) represents a remarkable 75% of cases 4
of anovulatory infertility (Dunaif and Thomas, 2001; Ehrmann, 2005). This is a 5
heterogeneous disease frequently characterized by hyperandrogenemia, hirsutism, oligo- 6
or amenorrhea, insulin resistance and anovulation. However, the lack of a clear etiology 7
associated with these syndromes has led to multiple treatments with few effective 8
therapies for infertility. 9
Apoptosis is a physiological process that plays a critical role in the maintenance of 10
homeostasis in multicellular organisms (Schwartzman and Cidlowski, 1993). Signaling 11
for apoptosis occurs through multiple independent pathways that converge in a common 12
machinery of cell destruction. For example, several genes belonging to the bcl-2 family 13
may function as intracellular mediators of cell survival. The protein products of the bcl-14
2 and Bax genes have been described as anti- or proapoptotic factors, respectively 15
(Korsmeyer, 1992; Reed, 1994; Boise et al., 1993). Depending on the balance of these 16
proteins, the activation of the initiator caspase 9 and the sequential activation of several 17
effector caspases such as caspase 3 or 7, which promote apoptosis in various systems, 18
occurs (Budihardjo et al., 1999). 19
 Mahesh (Mahesh, 1966) and Greenblatt (Greenblatt and Mahesh, 1974) showed that 20
dehydroepiandrosterone (DHEA) and its sulfate derivative are among the first 21
androgens that increase during puberty in most patients with PCOS. It has been 22
demonstrated that the injection of DHEA to immature rats produces an animal model of 23
PCOS that exhibits the prominent features of human PCOS- i.e., the follicles undergo 24
atresia or exhibit various stages of cystogenesis up to complete pathological 25
transformation into follicular cysts (Roy et al., 1962; Anderson et al., 1992). Thus, this 26
model appears to be appropriate to study the process of follicular atresia in PCOS 27
stages.28
The ovarian cycle is characterized by extensive tissue remodeling, where 99% of 29
mammalian follicles fail to ovulate and become atretic by a hormonally controlled 30
apototic process (Hsueh et al., 1996). Although Bcl-2 family protein members are 31
involved in this process, their significance in PCOS development remains unclear. 32
Accordingly, the aim of the present study was to evaluate if the balance between the 33
ovarian expression of Bax (a proapoptotic protein) and Bcl-2 (an antiapoptotic protein) 34
is altered in a PCOS model developed in rats by DHEA administration. In addition, the 35
ovarian morphology and the circulating progesterone levels were evaluated. 36
37
Materials and Methods 38
39
Animal Treatments and Tissue Collection 40
General care and housing of rats was carried out at the Instituto de Biología y Medicina 41
Experimental (IByME), Buenos Aires, Argentina. Prepubertal rats were from our 42
colony. Immature female Sprague-Dawley rats (21-23 days old) were allowed food and 43
water ad libitum, kept at room temperature (21-23 ºC) on a 12L:12D cycle. To induce 44
the hyperandrogenic PCOS condition the protocol developed by (Henmi et al., 2001) 45
was used. Rats were injected s.c. with DHEA (PCOS group, 6 mg/100 g body 46
weight/0.2 ml sesame oil, n=4-6) every evening for 15 days. Control animals were 47
injected with 0.2 ml of sesame oil every evening for an equivalent length of time 48
(Control group, n=4-6). There were no signs of inflammation at the injection sites 49
throughout the experiment. The animals were either euthanized by CO2 asphyxiation or 50
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4decapitated to obtain blood samples for steroid extraction. The plasma was stored at -20 1
ºC for subsequent RIA analysis. Ovaries were removed and cleaned of adhering tissue; 2
one ovary per rat was used for Western immunoblot assays and the other for 3
immunohistochemical assays.  4
5
Immunohistochemistry6
Ovaries from both the control and the PCOS group were obtained and immediately 7
fixed in 4% neutral buffered formalin for 12 h and then embedded in paraffin. Five-8
micron step sections were mounted at 50-µm intervals onto microscope slides to prevent 9
counting the same follicle twice, according to Woodruff et al. (Woodruff et al., 1990). 10
Tissue sections were treated as previously described (Abramovich et al., 2010). Sections 11
were incubated with goat polyclonal anti-Bcl-2 (1:100) or rabbit polyclonal anti-Bax 12
(1:100) primary antibodies. Specificity for Bcl-2 and Bax was supported by the loss of 13
staining in follicular tissue preabsorbed with their respective peptides from Santa Cruz 14
Biotechnology, Inc. (Santa Cruz, CA). 15
Morphological characteristics of preantral follicles (PF) include their size (PF:  120-200 16
Pm) and an oocyte surrounded by 2-4 layers of granulosa cells. Antral follicles (AF) are 17
defined as follicles of 200-500 Pm in diameter with a well-defined and thick granulosa 18
layer and an internal and external thecal layer (Hughes Jr. and Gorospe, 1991; 19
Hirshfield and Midgley, Jr., 1978). Cystic follicles were characterized by a thickened 20
theca interna layer and a diminished granulosa cell layer. 21
Atresia was defined as the presence of >10 pyknotic granulosa cells; in the smallest 22
follicles, the criterion for atresia was a degenerated oocyte and/or precocious antrum 23
formation (Andreu et al., 1998). 24
25
Western blot 26
Five ovaries per group were resuspended in 350Pl of lysis buffer (20 mM Tris-HCl [pH 27
8], 137 mM NaCl, 1% NP-40, and 10% glycerol) supplemented with protease inhibitors 28
(0.5 mM PMSF, 0.025 mM N-CBZ-L-phenylalanine chloromethyl ketone, 0.025 mM 29
N-p-tosyl-lysine chloromethyl ketone, and 0.025 mML-1-tosylamide-2-phenyl-30
ethylchloromethyl ketone) (all the products were obtained from Sigma) and 31
homogenized with an Ultra-Turrax (IKA Werk, Breisgau, Germany) homogenizer. 32
Samples were centrifuged at 4°C for 10 min at 10 000 x g, and the resulting pellets 33
discarded. Protein concentration in the supernatant was measured by the Bradford assay. 34
Western blot technique was performed as previously described (Abramovich et al., 35
2010). Blots were incubated with anti-Bax (1/200); anti Bcl-2 (1/500) and anti-actin B 36
(1/1.000) primary antibodies. Blots were then incubated with anti-rabbit or anti-mouse 37
antibodies conjugated with horseradish peroxidase (1:1000) and finally detected by 38
chemiluminescence and autoradiography with an x-ray film.  39
40
Quantification for the Western Immunoblot 41
In each experiment, equal amounts of protein were loaded for all samples, and protein 42
extracts from the PCOS and Control groups were loaded on the same gel. For 43
quantification, a screening was performed on blots with an x-ray film using different 44
times of exposure to optimize the signal. The density of each band was normalized to 45
the density of the actin B band that was used as an internal control. The levels of protein 46
were compared and analyzed with densitometric studies by Scion Image for Windows 47
(Scion Corporation, NIH, Washington, D.C.). Optical density data are expressed as 48
arbitrary units ± SEM. 49
50
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5Serum progesterone levels 1
Following ether extraction, serum steroid levels were measured by RIA in rats from the 2
Control and PCOS groups, as described previously (Saragueta et al., 1989; Irusta et al.,3
2003). Progesterone was measured using a specific antibody supplied by Dr. G. D. 4
Niswender (Animal Reproduction and Biotechnology Laboratory, Colorado State 5
University, Fort Collins, CO). Under these conditions, the intra-assay and inter-assay 6
variations were 8.0 and 14.2% respectively. 7
8
Data Analysis 9
Data are expressed as the mean ± SEM. Three different experiments with 4-6 ovaries 10
each were carried out for Western blot analysis and representative gels are shown in the 11
figures. Statistical analysis was performed with a paired t-Test using the GraphPad 12
Prism program version 4.00. Values of p<0.05 were considered significantly different.13
14
Results15
16
Morphological Studies and Serum Progesterone Levels 17
Ovarian histology confirmed the presence of follicular cysts and many atretic follicles 18
and the absence of corpora lutea in the rat ovaries from the PCOS group (Fig. 1B). In 19
contrast, Control ovaries showed the presence of numerous growing follicles and some 20
corpora lutea (Fig. 1A).21
Progesterone concentration in serum was measured after 15 days of DHEA treatment 22
(PCOS group) and in control animals (Control group). A significant decrease in 23
circulating progesterone levels was observed in the PCOS group (Control: 11.7 ± 2.3 24
ng/ml; PCOS: 4.8 ± 1.3 ng/ml, n=8, p<0.05). 25
26
Analysis of Bcl-2 and Bax in the ovaries from the PCOS and Control groups 27
Figure 2 shows the immunohistochemical staining for Bcl-2 in ovarian sections from 28
PCOS and Control rats during the different follicular stages. In the Control group, we 29
found that Bcl-2 was expressed in granulosa cells (Gc) at all follicular stages. In 30
contrast, no immunostaining for Bcl-2 was observed in thecal cells (Tc) (Fig. 2). In 31
preantral follicles we detected minimal expression of this protein (Fig. 2A). However, 32
intense immunostaining for Bcl-2 was observed in antral follicles (Fig. 2C). In PCOS 33
rats, Bcl-2 protein was either absent in preantral follicles (Fig. 2B) or weakly expressed 34
in Gc in antral follicles (Fig. 2D). In contrast, atretic follicles showed and intense 35
staining for Bcl-2 in ovarian sections from both groups (Fig. 2E-F).   36
Figure 3 shows the immunohistochemical staining for Bax in ovarian sections from 37
Control and PCOS rats. In Gc from the Control group, Bax protein was either absent in 38
preantral follicles (Fig. 3A) or moderately expressed in antral follicles (Fig. 3C). In 39
contrast, Bax expression was greater in Gc from preantral and antral PCOS follicles 40
(Fig. 3B & 3D). Antral ovarian follicles from Control and PCOS rats showed a weak 41
Bax expression in Tc, whereas preantral follicles showed total absence of expression 42
(Fig. 3A-D). In addition, atretic follicles showed an intense staining for Bax in ovarian 43
sections from both groups (Fig. 3E-F).44
In addition, follicular cysts from the rat ovaries of the PCOS group showed a weak 45
expression of Bcl-2 in Gc (Fig. 2H) and an intense expression of Bax (Fig. 3H). 46
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6Figure 4 shows the expression of ovarian Bcl-2 and Bax protein determined by Western 1
immunoblot. No differences in Bax ovarian levels were detected between groups (Fig. 2
4A). However, expression of Bcl-2 protein was lower (p<0.05) in ovaries from PCOS 3
rats than in those from Control rats (Fig. 4B). In addition, the Bax/ Bcl-2 ratio was 4
significantly increased in the PCOS group in comparison to the Control group (Fig. 4C). 5
6
Discussion  7
8
9
The present study investigated the protein expression levels and cellular localization of 10
Bcl-2 and Bax in ovaries from DHEA-induced PCOS rats. In order to correlate these 11
results with morphological and functional ovarian changes, ovarian structures were also 12
examined and serum progesterone levels measured.  13
Histological studies confirmed the presence of follicular cysts and many atretic follicles 14
and the absence of corpora lutea in the ovaries from the PCOS group and, as a 15
consequence, a significant decrease in the circulating progesterone levels. Our data 16
constitute the first evidence that these alterations are associated with changes in the 17
expression of ovarian apoptotic proteins of the Bcl-2 family. We demonstrated by 18
immunohistochemical studies that the expression of Bcl-2 and Bax was mainly 19
localized in granulosa cells (Gc) of antral follicles both in control and PCOS rats, 20
pointing out the importance of Gc during the process of follicular atresia and 21
cystogenesis observed in PCOS ovaries. However, Bax expression was greater in Gc of 22
preantral and antral follicles from PCOS ovarian sections than in those from the Control 23
group.  In contrast, intense Bcl-2 immunostaining was observed in Control antral 24
follicles, while Bcl-2 protein was either absent in preantral follicles or weakly 25
expressed in antral follicles from PCOS rats. These results were partially confirmed by 26
western immunoblot studies. Our data revealed that the ovarian level of Bcl-2 protein 27
was lower in ovaries from PCOS rats than in those from Control rats, and that no 28
changes in Bax ovarian levels were detected between groups. The different expression 29
of Bax observed using immunohistochemical assays could be due to the fact that for 30
Western blots the whole ovary was used, while immunohistochemical studies detect the 31
staining in each follicular stage. A possible dilution could take place when the total 32
ovarian level of Bax was measured. Nevertheless, the Bax/ Bcl-2 ratio measured by 33
Western blots was significantly higher in the PCOS group than in the Control group.34
35
Tilly et al have demonstrated that follicular atresia is associated with an imbalance 36
among the Bcl-2 family members. Gonadotropin treatment inhibits granulosa cell 37
apoptosis and follicular atresia mediated by the reduction of granulosa Bax expression 38
while maintaining the levels of Bcl-2 and Bcl-xL (Tilly, 1996; Tilly et al., 1995). Thus, 39
it was postulated that the intrinsic pathway of apoptosis would be involved in follicular 40
atresia (Tilly et al., 1995;Tilly, 1996). In addition, in a previous study, we have shown 41
that the local inhibition of Vascular Endothelial Gorwth Factor A (VEGFA) activity 42
appears to cause an increase in ovarian apoptosis through an imbalance among the Bcl-43
2 family members, thus leading a larger number of follicles to atresia (Abramovich et44
al., 2006). Moreover, in vivo GnRH agonist treatment caused an increase in follicular 45
atresia and apoptosis process in follicles from eCG- treated rats, which is correlated 46
with a decrease in the ratio of anti-apoptotic: proapoptotic proteins, as observed for the 47
Bcl-xL/Bcl-xS pair (Parborell et al., 2002). A similar mechanism could take part in the 48
development of the PCOS state induced by high levels of androgens (Tilly and Tilly, 49
1995; Parborell et al., 2002). Accordingly, the present data indicate that the intrinsic 50
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7pathway participates in the transformation of growing follicles in cystic follicles in the 1
ovaries from DHEA-induced PCOS rats. In an earlier study, Honnma et al (Honnma et 2
al., 2006) demonstrated that the extrinsic apoptotic pathway is also involved in the 3
mechanisms of follicular atresia in rat ovaries affected by PCOS induced by DHEA. In 4
the same animal PCOS model used in this study, these authors found an increase in the 5
number of apoptotic follicle cells and in the ovarian levels of the proapoptotic protein 6
FasL and the processed caspase-8 protein. All these data lead us to suggest that both 7
pathways may be involved in the development of the PCOS stage. In addition, our 8
results are in agreement with those obtained by Salvetti et al. in a different PCOS 9
model. In rats exposed to continuous light they described changes in the ovarian 10
expression of Bcl-2 family members using immunodetection assays (Salvetti et al., 11
2009).12
Apoptosis is related to the oxidant-antioxidant equilibrium. Thus, damage to biological 13
systems caused by the excess of reactive oxygen species (ROS) produce cellular 14
oxidative stress. It has been reported that hyperandrogenization of BALB/c mice with 15
DHEA prevents ovulation by increasing ovarian oxidative stress and altering the 16
endocrine and immune systems (Elia et al., 2006; Luchetti et al., 2004; Sander et al., 17
2005; Solano et al., 2006; Belgorosky et al., 2010). These alterations could be 18
associated with the changes in the expression of the apoptotic proteins described in this 19
study.20
In summary, our data demonstrate that the Bax/ Bcl-2 ratio was significantly higher in 21
the ovaries from the PCOS group than in those from the Control group. Thus, changes 22
in the intrinsic pathway of apoptosis are associated to the ovarian alterations observed 23
in the ovaries from DHEA-induced PCOS rats. 24
25
Conclusions26
27
Our data suggest that an increase in ovarian apoptosis through an imbalance among the 28
Bcl-2 family members may be involved in the transformation of growing follicles in 29
cystic follicles in the ovaries from DHEA-induced PCOS rats. 30
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Figure legends8
9
Figure 1. Representative photomicrographs of ovarian sections stained with 10
hematoxylin-eosin. A: normal cycling control rat treated with vehicle. B: PCOS rat 11
treated with 6 mg DHEA/100 g body weight for 15 days. Note the presence of 12
numerous growing follicles (F) and some corpora lutea (CL) in Fig. 1A and numerous 13
cystic follicles (Cy), atretic follicles (At) and the absence of corpora lutea in Fig. 1B. 14
Figure 2. Immunohistochemical staining for Bcl-2 in representative ovarian sections 15
from Control and PCOS rats showing different follicular stages. Panels A, C and E 16
show representative fields of ovarian sections from Control rats. Panels B, D, F and H 17
show representative fields of ovarian sections from PCOS rats. Panel G: negative 18
control. Specificity for Bcl-2 is supported by the loss of staining in follicular tissue 19
preabsorbed with Bcl-2 peptide (not shown). PF, preantral follicle; AF, antral follicle; 20
At: atretic follicle; Cy: cystic follicles Gc, granulosa cells; Tc, theca cells; Oo, oocyte; 21
St, stroma. Scale bars represent 50 Pm.22
Figure 3. Immunohistochemical staining for Bax in representative ovarian sections 23
from PCOS and Control rats showing the different follicular stages. Panels A, C and E 24
show representative fields of ovarian sections from Control rats. Panels B, D, F and H 25
show representative fields of ovarian sections from PCOS rats. Panel G: negative 26
control. Specificity for Bax is supported by the loss of staining in follicular tissue in the 27
absence of the primary antibody (not shown). PF, preantral follicle; AF, antral follicle; 28
At: atretic follicle; Cy: cystic follicles; Gc, granulosa cells; Tc, theca cells; Oo, oocyte; 29
St, stroma. Scale bars represent 50 Pm.30
Figure 4. Effect of DHEA treatment on proapoptotic and antiapoptotic ovarian protein 31
content. After homogenization, proteins were extracted, subjected to 12% SDS-PAGE, 32
and transferred onto nitrocellulose membranes. A) Upper panel: Densitometric 33
quantification of Bax content. Bars represent the mean ± SEM normalized to actin B. 34
Lower panel: Representative immunoblot of Bax ovarian protein content from control 35
and DHEA-treated rats (PCOS group). Bax protein was visualized with an anti-Bax 36
antibody. No differences in Bax ovarian levels were detected between groups. B) Upper 37
panel: Densitometric quantification of Bcl-2 content. Bars represent the mean ± SEM 38
normalized to actin B. Lower panel: Representative immunoblot of Bcl-2 protein 39
content in antral follicles from control and DHEA-treated rats (PCOS group). Bcl-2 40
protein was visualized with an anti-Bcl-2 antibody. Levels of Bcl-2 protein were 41
significantly decreased after DHEA treatment (n = 5; p < 0.05). C) Ratio Bax/Bcl-2 in 42
the PCOS and Control groups. The ratio was significantly increased after DHEA 43
treatment (n = 5; p < 0.05).  44
45
46
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